Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Non-Current Debt: 2020-2024

Historic Non-Current Debt for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Dec 2024 value amounting to $290.5 million.

  • Maravai Lifesciences Holdings' Non-Current Debt fell 44.34% to $287.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $287.4 million, marking a year-over-year decrease of 44.34%. This contributed to the annual value of $290.5 million for FY2024, which is 44.00% down from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Non-Current Debt stood at $290.5 million for FY2024, which was down 44.00% from $518.7 million recorded in FY2023.
  • Maravai Lifesciences Holdings' 5-year Non-Current Debt high stood at $713.5 million for FY2021, and its period low was $290.5 million during FY2024.
  • In the last 3 years, Maravai Lifesciences Holdings' Non-Current Debt had a median value of $518.7 million in 2023 and averaged $443.7 million.
  • Its Non-Current Debt has fluctuated over the past 5 years, first skyrocketed by 34.97% in 2021, then slumped by 44.00% in 2024.
  • Yearly analysis of 5 years shows Maravai Lifesciences Holdings' Non-Current Debt stood at $528.6 million in 2020, then skyrocketed by 34.97% to $713.5 million in 2021, then fell by 26.84% to $522.0 million in 2022, then decreased by 0.63% to $518.7 million in 2023, then tumbled by 44.00% to $290.5 million in 2024.